Document is current
Any future updates will be listed below
-
Authors
McCoy, Liam G. https://orcid.org/0000-0002-4468-2256
Bihorac, Azra https://orcid.org/0000-0002-5745-2863
Celi, Leo Anthony https://orcid.org/0000-0001-6712-6626
Elmore, Matthew https://orcid.org/0000-0003-1452-5281
Kewalramani, Divya https://orcid.org/0009-0004-9125-0909
Kwaga, Teddy https://orcid.org/0000-0002-5145-8017
Martinez-Martin, Nicole https://orcid.org/0000-0001-9345-0462
Prôa, Renata https://orcid.org/0000-0002-4265-7487
Schamroth, Joel https://orcid.org/0009-0004-4565-2333
Shaffer, Jonathan D. https://orcid.org/0000-0001-8933-6915
Youssef, Alaa https://orcid.org/0000-0001-6505-8236
Fiske, Amelia https://orcid.org/0000-0001-7207-6897
-
Funding
Funding for this research was provided by:
National Institute of Health (R01 EB017205)
DS-I Africa (U54 TW012043-01)
Bridge2AI (OT2OD032701)
National Science Foundation (ITEST #2148451)
Korea Health Industry Development Institute (RS-2024-00403047)
Technische Universität München
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 15 April 2025
First Online: 2 May 2025
Declarations
:
: Not applicable.
: Not applicable.
: LAC declares consulting fees from Philips for evaluation of hemodynamic monitoring product; payment/honoraria from Stanford University (visiting professor), University of California San Francisco (visiting professor), University of Toronto (visiting professor), and Taipei Medical University (remote speaker); support for attending meetings and/or travel from Australia New Zealand College of Intensive Care Medicine, University of Bergen, University Medical Center Amsterdam, Académie Nationale de Médecine (France), and the Doris Duke Foundation; leadership/fiduciary roles with PLOS Digital Health (Editor-in-Chief) and The Lancet Digital Health (International Advisory Board member); and receives compute credits for Oracle. JS is also an employee of GSK (a private company) and holds shares in the GSK group of companies. The remaining authors declare no competing interests.
